Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07650058 · ClinicalTrials.gov registry record · NA
Postprandial Effects of Fresh Mango as a Table Sugar Replacement in High-Sugar Breakfasts.
A NA study, sponsored by Ball State University.
- Recruiting
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT07650058 is a NA study that is actively recruiting participants, run by Ball State University. The registered enrollment target is 35 participants.
The verdict
NCT07650058, a NA study, is actively recruiting participants, sponsored by Ball State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
Systemic inflammation and intestinal hyperpermeability (disruption of the gut barrier which allows nutrient molecules and bacteria to enter the bloodstream) are triggered by consumption of high-sugar meals and are linked to future development of cardiovascular disease (CVD). Previous research indicates that fresh mangos have properties that have positive effects on the intestinal barrier and local gut inflammation. The investigators want to understand if replacing table sugar (sucrose) with sugar from fresh mango (which also contains fiber and plant bioactives) will lead to decreased inflammatory and permeability biomarkers after eating a high-sugar breakfast. The investigators will compare the postprandial (post meal) levels of inflammatory (IL-6) and permeability (LPS, lipid binding protein (LBP), and soluble CD14) biomarkers in blood from participants who have consumed a meal sweetened with either sucrose or fresh mango.
Interventions
- OTHER High-Glycemic Breakfast Containing Cereal and Table Sugar
- OTHER High-Glycemic Breakfast Containing Cereal and Fresh Mango
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2026-02-01 |
| Est. Completion | 2027-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07650058
The ClinicalTrials.gov registry entry for NCT07650058 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ball State University, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which High-Glycemic Breakfast Containing Cereal and Table Sugar is the first listed.
NCT07650058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07650058 about?
NCT07650058 is a clinical study titled "Postprandial Effects of Fresh Mango as a Table Sugar Replacement in High-Sugar Breakfasts.". Systemic inflammation and intestinal hyperpermeability (disruption of the gut barrier which allows nutrient molecules and bacteria to enter the bloodstream) are triggered by consumption of high-sugar meals and are linked to future development of cardiovascular disease (CVD). Previous research indica...
What is the current status of trial NCT07650058?
This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2026-02-01. Estimated completion is 2027-01.
What interventions are being tested in trial NCT07650058?
The interventions under investigation include: High-Glycemic Breakfast Containing Cereal and Table Sugar (OTHER), High-Glycemic Breakfast Containing Cereal and Fresh Mango (OTHER).
Who is sponsoring clinical trial NCT07650058?
This trial is sponsored by Ball State University, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.